Stacey Schutte

Dr. Stacey Schutte

Biomedical Engineering, University of Cincinnati, Cincinnati, Ohio, USA
orcid
Assistant Professor

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 October 2010 in Tissue Engineering Part A
Verified
Journal Article
Closed access
Stacey SchutteStacey Schutte
Stacey Schutte
ZCZhenzhen Chen
Zhenzhen Chen
KBKelvin G.M. Brockbank
Kelvin G.M. Brockbank
RNRobert M. Nerem
Robert M. Nerem
Tissue-engineered blood vessels may provide a solution to the lack of suitable blood vessels for coronary and peripheral vessel bypass grafting. Cyclic strain can be used to provide a more physiological environment that may result in tissue that more closely resembles native artery. In this study, cyclic strain is applied to a collagen-based, tissue-engineered vascular medium. An increased culture time was used to allow the tissue to adhere to the silastic sleeve and to eliminate longitudinal compaction. Cyclic strain improved tissue strength through increased collagen content as well as some radial tissue compaction. Mechanical stimulation promoted a more contractile phenotype and led to a greater contractile response to the vasoconstrictor endothelin-1.

1 March 2015 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
Stacey SchutteStacey Schutte
Stacey Schutte
CJChristopher O. James
Christopher O. James
NSNeil Sidell
Neil Sidell
RTRobert N. Taylor
Robert N. Taylor

17 August 2019 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
SRScott J Rapp
Scott J Rapp
VDVictoria Dershem
Victoria Dershem
XZXiang Zhang
Xiang Zhang
Stacey SchutteStacey Schutte
Stacey Schutte
MCMark E Chariker
Mark E Chariker
Over 6.5 million people in the United States suffer from traumatic, burn, acute, and chronic wounds yearly. When reconstruction is required, split and full-thickness autografts are a first line of treatment intervention. Negative pressure wound therapy (NPWT) is gaining traction as an adjunct modality to improve graft survival, yet the specifics on what settings to apply topically over the graft is unsubstantiated and associated with morbidities. This study was performed in an effort to understand initial changes in wound and graft healing with a long-term goal of surface pressure optimization. Excess skin from elective procedures from six human subjects was trimmed to 0.012 inch in order represent a split-thickness autografts. These grafts were treated continuously with either −75 mm Hg (n = 4), −125 mm Hg (n = 4), or no pressure (n = 4) for 3 hours. Six skin grafts were treated with no sponge or pressure control (n = 6). RNAseq was performed on all treatment groups and compared with no pressure control. Significant gene expression changes with a subset focusing on inflammatory, cellular/extracellular matrix proliferation and angiogenic mediators and having greater than 2-fold were confirmed with immunohistochemistry staining. There are 95 significant gene transcription differences among all treatment groups. NPWT leads to significantly increased gene expression of FGFR1, ET-1, and 22 Keratin proteins. Between −75 and −125 mm Hg groups, there are 19 significant gene changes. Proinflammatory genes S100A8 and Tenacin C (TNC) demonstrate an 8.8- and 9.1-fold change, respectively, and is upregulated in −125 mm Hg group and downregulated in −75 mm Hg group. Fibrinogen genes fibrinogen gamma chain and fibrinogen alpha chain had respective log2-fold changes of −7.9 and −7.4 change between treatment groups and were downregulated in −125 mm Hg group and upregulated in −75 mm Hg group. There are varying effects of surface pressures on human split-thickness autografts during the imbibition time period. NPWT may improve cellular migration, proliferation, and angiogenesis over controls. Human skin grafts respond differently to −125 and −75 mm Hg within 3 hours of NPWT treatment. The results suggest −75 mm Hg leads to less inflammation and increased fibrinogen production compared with the −125 mm Hg group, at least initially. Reducing “time to heal” with NPWT is critical to successful outcomes and quality of life within young patients who often experience pain/discomfort when treated at the current standard pump settings. The results from this study and continued investigation may quickly translate to the clinical setting by finding the ideal pressure setting utilized in an effort to reduce NPWT length of treatment, improve patient comfort, satisfaction, and psychosocial well-being.

6 April 2016 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
JPJon F. Pennycuff
Jon F. Pennycuff
Stacey SchutteStacey Schutte
Stacey Schutte
CHCatherine O. Hudson
Catherine O. Hudson
DKDeborah R. Karp
Deborah R. Karp
AMAnna P. Malykhina
Anna P. Malykhina
GNGina M. Northington
Gina M. Northington

1 February 2021 in Tissue Engineering Part C: Methods
Verified
Journal Article
Closed access
Stacey SchutteStacey Schutte
Stacey Schutte
FKFeni Kadakia
Feni Kadakia
SDSteve Davidson
Steve Davidson
Prominent clinical problems related to the skin-nerve interface include barrier dysfunction and erythema, but it is the symptoms of pain and itch that most often lead patients to seek medical treatment. Tissue-engineered innervated skin models provide an excellent solution for studying the mechanisms underlying neurocutaneous disorders for drug screening, and cutaneous device development. Innervated skin substitutes provide solutions beyond traditional monolayer cultures and have advantages that make them preferable to in vivo animal studies for certain applications, such as measuring somatosensory transduction. The tissue-engineered innervated skin models replicate the complex stratified epidermis that provides barrier function in native skin, a feature that is lacking in monolayer co-cultures, while allowing for a level of detail in measurement of nerve morphology and function that cannot be achieved in animal models. In this review, the advantages and disadvantages of different cell sources and scaffold materials will be discussed and a presentation of the current state of the field is reviewed. Impact statement: A review of the current state of innervated skin substitutes and the considerations that need to be addressed when developing these models. Tissue-engineered skin substitutes are customizable and provide barrier function allowing for screening of topical drugs and for studying nerve function.